Research & Development



  大長秋不斷地將手里的鵝蛋拋起,然後接住,慢悠悠的道︰“陛下來長門宮三趟了……”   “咦?這是什麼道理?”青青草国语   曹勝肥胖的臉上滿是油汗,堆滿了笑容道︰“換過來了,換過來了,七千畝上田換了這里三千畝荒地,別人都說我家侯爺是敗家子,他們知道個屁,只有我們這些常來雲家莊子的人才知道這筆買賣有多劃算。您看看,長門宮里的貴人不也開始開荒了嗎?”caoporn   雲瑯好不容易把老虎拽起來,喘著粗氣道︰“那是兩個聰明的婦人,知道自己想要什麼,知道什麼樣的人可以親近,什麼樣的人不能親近。在她們看來,你就屬于那種完全不可親近的人。”   這還是雲瑯第一次全副武裝縱馬狂奔,游春馬也非常的配合,踩著松軟的荒原,奔馳的越發急速。超碰在线   雲瑯放緩了馬速,讓游春馬自己慢慢的從疾馳改變成慢跑,最後緩緩走到營寨前面,等先到的曹襄報名入營。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo